echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > "Challenges Facing China's Pharmaceutical Innovation and Its Countermeasures" was first published on the whole network to help Chinese medicine meet innovation challenges

    "Challenges Facing China's Pharmaceutical Innovation and Its Countermeasures" was first published on the whole network to help Chinese medicine meet innovation challenges

    • Last Update: 2022-04-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The development of the pharmaceutical industry can escort the life and health of the people and the sustainable social and economic development, and occupies a special strategic position in the national economy


    The article points out that after a series of reforms over the past ten years, China has gradually built a relatively complete pharmaceutical innovation ecosystem and has become one of the highlands of global pharmaceutical innovation


    Focusing on the above problems, as a high-tech agglomeration biopharmaceutical industry, the Chinese pharmaceutical industry must improve its scientific and technological self-reliance and innovation capabilities, including: creating a new ecology for basic research and upgrading and transformation, activating the source of medical innovation; establishing clinical value.


    At present, China's pharmaceutical innovation has once again come to the key point of transformation.


    The original paper can be downloaded and read by scanning the QR code

    Note: The original paper was published in the Journal of Medicine and Philosophy, 2022, 43(2): 1-7.


    Note: The original paper was published in the Journal of Medicine and Philosophy, 2022, 43(2): 1-7.


    The pharmaceutical policy has guided the previous changes in the industry, throughout the entire process of pharmaceutical development, and the importance of domestic and foreign pharmaceutical policy research has become increasingly prominent


    The research center will gather domestic and foreign research elites in the field of pharmaceutical policy and pharmaceutical industry, cooperate with domestic and foreign policy, regulatory research institutions and consulting institutions to build a domestic first-class and internationally renowned third-party think tank to study and discuss China's pharmaceutical policy and the development of the pharmaceutical industry.


    "Medicine and Philosophy"

    "Medicine and Philosophy" is a national academic journal sponsored by the China Association for Science and Technology and sponsored by the Chinese Society for Dialectics of Nature


    It is now included in "Chinese Core Journals", "China Science and Technology Core Journals" (China Science and Technology Paper Statistics Source Journals), "China Humanities and Social Sciences Citation Database Source Journals" and "RCCSE China Core Academic Journals"


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.